Keisuke Suzuki

Dichloroacetate induces regulatory T‐cell differentiation and suppresses Th17‐cell differentiation by pyruvate dehydrogenase kinase‐independent mechanism

Naoyuki Makita, F. Nara, Jun Ishiguro, 2017, The Journal of pharmacy and pharmacology.

Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.

T. Ohnuki, T. Izumi, W. Tomisato, 2011, ACS medicinal chemistry letters.

Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.

S. Kumakura, Tomoko Yamada, S. Inoue, 2008, European journal of pharmacology.

Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P₁ agonists.

T. Fukuda, Tsuyoshi Nakamura, T. Izumi, 2014, Bioorganic & medicinal chemistry.

Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor

T. Horiuchi, M. Hirasawa, T. Takizawa, 2017, Cancer science.

Synthesis of a chiral phosphonium salt for the preparation of α-substituted alaninol derivatives

Tsuyoshi Nakamura, T. Tsuji, T. Nishi, 2014 .

Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17.

S. Sano, T. Isobe, M. Ishizaki, 2017, Journal of dermatological science.

Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy

G. Sobue, A. Nitta, H. Mizoguchi, 2010, The Journal of Neuroscience.